InspireMD (NSPR) Tops Q2 EPS by 19c

InspireMD (NASDAQ: NSPR) reported Q2 EPS of ($0.24), $0.19 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $1.8 million.

For earnings history and earnings-related data on InspireMD (NSPR) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Cheetah Net Supply Chain Service Inc. (CTNT) Reports Q2 EPS of $0.04
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94